Medartis Granted 510(k) for CalcShift Displacement Calcaneal Osteotomy System

Medartis received FDA 510(k) clearance to market its CalcShift System for displacement calcaneal osteotomies. The system is one of several new lower extremity products scheduled for launch in the U.S. in 2023.

Indicated for osteotomies, non-unions, malunions, revisions, fusions and reconstruction of the calcaneus requiring a medial or lateral...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0